Cloning, Purification, and Characterization of a β-Carbonic Anhydrase from


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
17 May 2019
Historique:
received: 03 05 2019
revised: 13 05 2019
accepted: 15 05 2019
entrez: 22 5 2019
pubmed: 22 5 2019
medline: 13 11 2019
Statut: epublish

Résumé

The cloning, purification, and initial characterization of the β-carbonic anhydrase (CA, EC 4.2.1.1) from the genome of the opportunistic pathogen

Identifiants

pubmed: 31108925
pii: ijms20102447
doi: 10.3390/ijms20102447
pmc: PMC6566260
pii:
doi:

Substances chimiques

Carbonic Anhydrase Inhibitors 0
Fungal Proteins 0
Sulfonamides 0
Carbon Dioxide 142M471B3J
Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Bioorg Med Chem Lett. 2004 Feb 23;14(4):869-73
pubmed: 15012984
Curr Med Chem Cardiovasc Hematol Agents. 2004 Jan;2(1):49-68
pubmed: 15328829
Bioinformatics. 2007 Nov 1;23(21):2947-8
pubmed: 17846036
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18730-5
pubmed: 18000048
Nat Rev Drug Discov. 2008 Feb;7(2):168-81
pubmed: 18167490
Curr Pharm Des. 2008;14(7):622-30
pubmed: 18336307
Bioorg Med Chem Lett. 2008 Sep 15;18(18):5066-70
pubmed: 18723348
J Mol Biol. 2009 Jan 30;385(4):1207-20
pubmed: 19071134
J Med Chem. 2009 May 14;52(9):3116-20
pubmed: 19338333
J Med Chem. 2009 Jul 9;52(13):4063-7
pubmed: 19438226
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Curr Pharm Des. 2010;16(29):3300-9
pubmed: 20819064
Nat Rev Drug Discov. 2011 Sep 16;10(10):767-77
pubmed: 21921921
Expert Opin Emerg Drugs. 2012 Mar;17(1):11-5
pubmed: 22335448
J Med Chem. 2012 Apr 12;55(7):3513-20
pubmed: 22424239
Chem Rev. 2012 Aug 8;112(8):4421-68
pubmed: 22607219
Expert Opin Ther Pat. 2012 Jul;22(7):747-58
pubmed: 22697257
Expert Opin Ther Pat. 2013 Feb;23(2):203-13
pubmed: 23148584
J Med Chem. 2012 Dec 13;55(23):10742-8
pubmed: 23181552
J Enzyme Inhib Med Chem. 2013 Apr;28(2):229-30
pubmed: 23379684
PLoS One. 2013;8(3):e58203
pubmed: 23483996
J Biol Chem. 2014 May 2;289(18):12647-56
pubmed: 24627479
J Enzyme Inhib Med Chem. 2015 Apr;30(2):325-32
pubmed: 24766661
J Enzyme Inhib Med Chem. 2015 Apr;30(2):277-82
pubmed: 25007132
Curr Med Chem. 2015;22(18):2130-9
pubmed: 25312213
J Enzyme Inhib Med Chem. 2015 Dec;30(6):920-4
pubmed: 25676328
Exp Dermatol. 2015 May;24(5):398-400
pubmed: 25739873
J Enzyme Inhib Med Chem. 2016;31(3):417-24
pubmed: 25945748
J Enzyme Inhib Med Chem. 2016 Oct;31(5):689-94
pubmed: 26118417
Expert Opin Ther Targets. 2015;19(12):1689-704
pubmed: 26235676
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5194-8
pubmed: 26459213
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1156-61
pubmed: 26523349
J Enzyme Inhib Med Chem. 2016;31(3):345-60
pubmed: 26619898
Acta Crystallogr D Biol Crystallogr. 2015 Dec 1;71(Pt 12):2449-56
pubmed: 26627652
Future Med Chem. 2016;8(3):311-24
pubmed: 26898220
Bioorg Med Chem Lett. 2016 Apr 15;26(8):1941-6
pubmed: 26972117
Sci Rep. 2016 May 12;6:24877
pubmed: 27172459
Bioorg Med Chem. 2016 Aug 15;24(16):3413-7
pubmed: 27283786
Biochem J. 2016 Jul 15;473(14):2023-32
pubmed: 27407171
Expert Opin Drug Discov. 2017 Jan;12(1):61-88
pubmed: 27783541
Bioorg Med Chem. 2017 Feb 1;25(3):1260-1265
pubmed: 28057408
Exp Dermatol. 2017 Sep;26(9):835-838
pubmed: 28094891
Bioorg Med Chem. 2017 May 1;25(9):2577-2582
pubmed: 28343756
Curr Med Chem. 2017;24(22):2392-2412
pubmed: 28393697
J Enzyme Inhib Med Chem. 2017 Dec;32(1):1064-1070
pubmed: 28766952
Metabolites. 2017 Sep 16;7(3):null
pubmed: 28926956
Curr Opin Microbiol. 2017 Dec;40:81-87
pubmed: 29141240
ACS Med Chem Lett. 2017 Oct 20;8(11):1194-1198
pubmed: 29152053
J Enzyme Inhib Med Chem. 2018 Dec;33(1):139-146
pubmed: 29192555
J Enzyme Inhib Med Chem. 2018 Dec;33(1):286-289
pubmed: 29278948
J Enzyme Inhib Med Chem. 2018 Dec;33(1):485-495
pubmed: 29390912
Metabolites. 2018 Mar 21;8(2):null
pubmed: 29561812
ChemMedChem. 2018 Apr 23;13(8):816-823
pubmed: 29575699
Expert Opin Ther Pat. 2018 Oct;28(10):745-754
pubmed: 29973089
Med Mycol. 2019 Apr 1;57(3):e2
pubmed: 30010938
Expert Opin Ther Pat. 2018 Oct;28(10):729-740
pubmed: 30074415
ChemMedChem. 2018 Oct 8;13(19):2024-2029
pubmed: 30088334
Expert Opin Ther Pat. 2018 Oct;28(10):713-721
pubmed: 30175635
Expert Opin Ther Pat. 2018 Oct;28(10):709-712
pubmed: 30217119
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1299-1308
pubmed: 30249139
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1537-1544
pubmed: 30284487
Expert Opin Investig Drugs. 2018 Dec;27(12):963-970
pubmed: 30426805
Expert Opin Drug Discov. 2019 Mar;14(3):231-248
pubmed: 30681011
Bioorg Chem. 2019 May;86:39-43
pubmed: 30684862
J Enzyme Inhib Med Chem. 2019 Dec;34(1):644-650
pubmed: 30727781
Microbiol Resour Announc. 2019 Feb 7;8(6):null
pubmed: 30746521
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063

Auteurs

Sonia Del Prete (S)

Istituto di Bioscienze e Biorisorse, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy. sonia.delprete@ibbr.cnr.it.

Daniela Vullo (D)

Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy. daniela.vullo@unifi.it.

Cynthia Ghobril (C)

L'Oréal Research and Innovation, 93601 Aulnay-sous-Bois, France. cynthia.ghobril@rd.loreal.com.

Julien Hitce (J)

L'Oréal Research and Innovation, 93601 Aulnay-sous-Bois, France. julien.hitce@rd.loreal.com.

Cécile Clavaud (C)

L'Oréal Research and Innovation, 93601 Aulnay-sous-Bois, France. cecile.clavaud@rd.loreal.com.

Xavier Marat (X)

L'Oréal Research and Innovation, 93601 Aulnay-sous-Bois, France. xavier.marat@rd.loreal.com.

Clemente Capasso (C)

Istituto di Bioscienze e Biorisorse, CNR, Via Pietro Castellino 111, 80131 Napoli, Italy. clemente.capasso@ibbr.cnr.it.

Claudiu T Supuran (CT)

Dipartimento Neurofarba, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Via U. Schiff 6, 50019 Sesto Fiorentino, Florence, Italy. claudiu.supuran@unifi.it.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH